Silexion Therapeutics Corp (SLXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 3,680 | 2,749 | 4,406 | 3,292 | 2,284 |
| Operating Income | -3,680 | -2,749 | -4,406 | -3,292 | -2,284 |
| Interest Expense | -129 | -16 | 6 | -30 | 216 |
| Pre-tax Income | -3,551 | -2,733 | -4,412 | -3,262 | -2,500 |
| Income Tax | 0 | 0 | N/A | 0 | 3 |
| Net Income Continuous | -3,551 | -2,733 | -4,412 | -3,262 | -2,503 |
| Net Income | $-3,551 | $-2,733 | $-4,412 | $-3,262 | $-2,503 |
| EPS Basic Total Ops | -5.17 | -8.50 | 20.79 | -28.80 | -43.19 |
| EPS Basic Continuous Ops | -5.17 | -8.46 | 20.74 | -28.79 | -43.16 |
| EPS Diluted Total Ops | -5.17 | -8.50 | 20.79 | -28.80 | -43.19 |
| EPS Diluted Continuous Ops | -5.17 | -8.46 | 20.74 | -28.79 | -43.16 |
| EPS Diluted Before Non-Recurring Items | -5.17 | -8.50 | N/A | -28.80 | -43.20 |
| EBITDA(a) | $-3,677 | $-2,747 | $-4,403 | $-3,288 | $-2,281 |